Nov 26, 2012, 11.53 AM IST
GlaxoSmithKline Plc plans to raise its stake in its Indian consumer products arm GlaxoSmithKline Consumer Healthcare Ltd to 75% from 43.16% through an open offer, the manager to the offer said on Monday.
GlaxoSmithKline along with its units will buy up to 13.39 million shares, or 31.84% in GlaxoSmithKline Consumer Healthcare, at Rs.3,900 per share, said HSBC Securities Ltd, the manager to the offer, in a statement.
As per Indian regulations, promoters of stock exchange-listed companies can hold up to a maximum of 75% stake. If the promoter shareholding rises beyond 75%, then the company has to be de-listed from the bourses.
GlaxoSmithKline Pharmaceuticals was quoting at Rs 2,085, up Rs 86.55, or 4.33%.
GlaxoSmithKline Consumer Healthcare was quoting at Rs 3,651.80, up Rs 608.60, or 20%. It has touched a 52-week high of Rs 3,651.80.
GlaxoSmith Con stock price
On December 12, 2013, GlaxoSmithKline Consumer Healthcare closed at Rs 4490.00, down Rs 21.35, or 0.47 percent. The 52-week high of the share was Rs 6020.00 and the 52-week low was Rs 3482.25.
The company's trailing 12-month (TTM) EPS was at Rs 117.21 per share as per the quarter ended September 2013. The stock's price-to-earnings (P/E) ratio was 38.31. The latest book value of the company is Rs 323.61 per share. At current value, the price-to-book value of the company is 13.87.
Action in GlaxoSmithKline Consumer Healthcare
Video of the day
Dec 11 2013, 09:54
- in Business
Dec 4 2013, 11:08
- in FII View
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.